Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State

Ipsen407 enrolled

Overview

The purpose of the protocol is to describe treatment patterns among patients with prostate cancer prior to diagnosis of castration-resistant state.

Study Type

OBSERVATIONAL

Enrollment

407

Conditions

Prostate Cancer

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥ 18 years * Patients with prostate cancer who had developed a castration resistant state in the last 24 months prior to starting the study * Patient must give written informed consent before any study related procedure Exclusion Criteria: * Patients with medical histories lacking data required to evaluate the study objectives

Locations (1)

Private practice, La Cañada, Paterna

Valencia, Spain

Outcomes

Primary Outcomes

Prior treatment before progression to advanced or metastatic disease.

Number of participants with each category of treatment.

Time frame: Baseline

Treatment of advanced or metastatic disease.

Number of participants with each category of treatment.

Time frame: Baseline

Secondary Outcomes

Clinical management of Castration-Resistant Prostate Cancer (CRPC) patients in the clinical practice.

Percentage of specialists (urologist, radiotherapist, oncologist or other specialist) in charge of treatment decision in CRPC patients.

Time frame: Baseline

Number of CRPC patients with signs and symptoms of metastatic disease.

Time frame: Baseline

Time to castration resistant state after beginning of hormonotherapy.

Time frame: Baseline

Demographic data.

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.